These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

327 related articles for article (PubMed ID: 33690022)

  • 21. Class 1 antiarrhythmic drugs--characteristic electrocardiographic differences when assessed by atrial and ventricular pacing.
    Milne JR; Hellestrand KJ; Bexton RS; Burnett PJ; Debbas NM; Camm AJ
    Eur Heart J; 1984 Feb; 5(2):99-107. PubMed ID: 6723689
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Flecainide acetate: concentration-response relationships for antiarrhythmic and electrocardiographic effects.
    Boriani G; Capucci A; Strocchi E; Calliva R; Santarelli A; Biffi M; Magnani B
    Int J Clin Pharmacol Res; 1993; 13(4):211-9. PubMed ID: 8150547
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evaluation of the efficacy of flecainide acetate in the treatment of ventricular premature contractions.
    Muhiddin KA; Turner P; Hellestrand K; Camm AJ
    Postgrad Med J; 1985 Jun; 61(716):489-96. PubMed ID: 2409543
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A life-threatening flecainide overdose treated with intravenous fat emulsion.
    Ellsworth H; Stellpflug SJ; Cole JB; Dolan JA; Harris CR
    Pacing Clin Electrophysiol; 2013 Mar; 36(3):e87-9. PubMed ID: 22882363
    [TBL] [Abstract][Full Text] [Related]  

  • 25. When potion becomes poison! A case report of flecainide toxicity.
    Bajaj S; Tullu MS; Khan Z; Agrawal M
    J Postgrad Med; 2017; 63(4):265-267. PubMed ID: 28272074
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cardiac electrophysiologic effects of flecainide acetate for paroxysmal reentrant junctional tachycardias.
    Hellestrand KJ; Nathan AW; Bexton RS; Spurrell RA; Camm AJ
    Am J Cardiol; 1983 Mar; 51(5):770-6. PubMed ID: 6829436
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pharmacokinetic-pharmacodynamic modeling of QRS-prolongation by flecainide: heart rate-dependent effects during sinus rhythm in conscious telemetered dogs.
    Sällström J; Al-Saffar A; Pehrson R
    J Pharmacol Toxicol Methods; 2014; 69(1):24-9. PubMed ID: 24140388
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Flecainide Toxicity Resulting in Pacemaker Latency and Intermittent Failure to Capture.
    Suffredini JM; Rutland J; Akpunonu P; Baum R; Catanzaro J; Elayi CS
    Am J Case Rep; 2019 Aug; 20():1279-1283. PubMed ID: 31467262
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Flecainide toxicity: ECG changes associated with supratherapeutic levels in milk-fed infants.
    Bhatt H; Regan W; Rosenthal E; Bellsham-Revell H
    BMJ Case Rep; 2023 Feb; 16(2):. PubMed ID: 36731946
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Fatal flecainide intoxication.
    Brazil E; Bodiwala GG; Bouch DC
    J Accid Emerg Med; 1998 Nov; 15(6):423-5. PubMed ID: 9825278
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Proarrhythmic effects of the new antiarrhythmic agent flecainide acetate.
    Nathan AW; Hellestrand KJ; Bexton RS; Banim SO; Spurrell RA; Camm AJ
    Am Heart J; 1984 Feb; 107(2):222-8. PubMed ID: 6695656
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Successful extracorporeal life support in a case of severe flecainide intoxication.
    Auzinger GM; Scheinkestel CD
    Crit Care Med; 2001 Apr; 29(4):887-90. PubMed ID: 11373489
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Flecainide poisoning and prolongation of elimination due to alkalinization.
    McCabe DJ; Walsh RD; Georgakakos PK; Radke JB; Wilson BZ
    Am J Emerg Med; 2022 Jun; 56():394.e1-394.e4. PubMed ID: 35287973
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of sodium channel blockers on ST segment, QRS duration, and corrected QT interval in patients with Brugada syndrome.
    Shimizu W; Antzelevitch C; Suyama K; Kurita T; Taguchi A; Aihara N; Takaki H; Sunagawa K; Kamakura S
    J Cardiovasc Electrophysiol; 2000 Dec; 11(12):1320-9. PubMed ID: 11196553
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Absorption kinetics and pharmacodynamics of two oral dosage forms of flecainide in patients with an episode of paroxysmal atrial fibrillation.
    Deneer VH; Lie-A-Huen L; Kingma JH; Proost JH; Gossen SA; Stuurman A; Uytdehaag GM; Dunselman PH; Brouwers JR
    Eur J Clin Pharmacol; 2004 Dec; 60(10):693-701. PubMed ID: 15619132
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Electrophysiologic effects of flecainide acetate on sinus node function, anomalous atrioventricular connections, and pacemaker thresholds.
    Hellestrand KJ; Nathan AW; Bexton RS; Camm AJ
    Am J Cardiol; 1984 Feb; 53(5):30B-38B. PubMed ID: 6695817
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Electrophysiological effects of the new antiarrhythmic drug flecainide (R 818) in man (author's transl)].
    Seipel L; Abendroth RR; Breithardt G
    Z Kardiol; 1981 Jul; 70(7):524-9. PubMed ID: 7269731
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Safe and efficacious dosage of flecainide acetate for treating equine atrial fibrillation.
    Ohmura H; Nukada T; Mizuno Y; Yamaya Y; Nakayama T; Amada A
    J Vet Med Sci; 2000 Jul; 62(7):711-5. PubMed ID: 10945288
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Impact of serum flecainide level on control of atrial fibrillation in a case treated with cardiac resynchronization therapy.
    Doki K; Homma M; Kuga K; Kawano S; Aonuma K; Yamaguchi I; Kohda Y
    J Clin Pharm Ther; 2007 Aug; 32(4):409-11. PubMed ID: 17635343
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Flecainide toxicity: a presentation to the emergency department with literature review.
    Ghataoura R; Patil S
    BMJ Case Rep; 2020 Feb; 13(2):. PubMed ID: 32114494
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.